HHS recently announced a plan supporting legislation that would allow it to negotiate Medicare Part B and Part D drug prices directly with pharmaceutical companies and then make those prices available to other purchasers, in addition to other key polic…
Month: September 2021
Diabetic Macular Edema: Mixed Results for Brolucizumab
Brolucizumab requires fewer injections but may also cause intraocular inflammation in treating diabetic macular edema. Medscape Medical News
Novel digital therapy for amblyopia demonstrates positive phase 3 results
Luminopia One, an investigational digital therapy that allows patients with amblyopia to watch visually modified TV shows and movies to improve vision, has shown positive results, according to a press release from Luminopia.The phase 3 multicenter, ran…
VIDEO: Novel biologic agent for treatment of non-anterior uveitis under investigation
In this video from the virtual Euretina congress, Quan Dong Nguyen, MD, MSc, speaks about ABY-035, a novel biologic compound that has been demonstrated to be a potent interleukin-17A inhibitor with unique pharmacological properties.ABY-035 (Affibody) i…
Visus Therapeutics Hosts Inaugural Capital Markets Day in New York City
SEATTLE–(BUSINESS WIRE)–Visus Therapeutics Inc., a clinical-stage pharmaceutical company focused on developing innovative ophthalmic therapies to improve vision for people around the world, recently welcomed investors, analysts and media to its inaug…
Aurion Biotech Announces Strategic Investments in Manufacturing
SEATTLE & BOSTON & TOKYO–(BUSINESS WIRE)–Aurion Biotech Makes Strategic Investments in Cell Therapy Production, Appoints Tim Largen VP Manufacturing
Luminopia One, a Digital Therapeutic for Amblyopia, Demonstrates Safety and Efficacy in Phase 3 Pivotal Trial
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Luminopia today announced the publication of positive Phase 3 pivotal data of its investigational treatment for amblyopia—Luminopia OneTM—in OphthalmologyⓇ, the journal of the American Academy of Ophthalmology. This i…
Global Ophthalmic Drug Delivery Devices Market (2021 to 2030) – Focus on Product, Formulation, Sales Channel, End-user and Region – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Ophthalmic Drug Delivery Devices Market: Focus on Product, Formulation, Sales Channel, End User, and 21 Countries – Analysis and Forecast, 2021-2030” report has been added to ResearchAndMarkets.com’s offering. The g…
Global Age-Related Macular Degeneration Markets and Competitive Landscape Report 2021 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Age-Related Macular Degeneration Market and Competitive Landscape – 2021” report has been added to ResearchAndMarkets.com’s offering. Global Age-Related Macular Degeneration Market and Competitive Landscape – 2021, …
Eye conditions linked to increased risk of dementia
Age-related macular degeneration, cataract and diabetes-related eye disease are linked to an increased risk of dementia, suggests research published online in the British Journal of Ophthalmology.
Emotional support and resilience can help mitigate the psychological effects of the pandemic
Health care workers with high resilience or strong emotional support were protected against the effects of stress related to the COVID-19 pandemic compared to those who had low emotional support or resilience, according to a study published September 1…
Largest population-based study tracks the prevalence of lazy eye among teens
An estimated 1% to 5% of children worldwide have lazy eye– a childhood condition where the vision does not develop properly.
Study finds possible direct connection between neurodegenerative diseases and the herpesvirus
A new study by researchers at University of Illinois Chicago suggests that when the protein optineurin, or OPTN, is present in cells it restricts the spread of HSV-1, the herpes simplex virus type 1.
GT005 gene therapy shows ability to modulate complement pathway in geographic atrophy
In a first-in-human phase 1/2 study, GT005, an AAV2-based one-time investigational gene therapy, showed potential to regulate the complement pathway involved in the pathogenesis of geographic atrophy.The complement system has a key role in the pathogen…
VIDEO: Euretina Lecture focuses on key role of choriocapillaris in AMD
In his keynote Euretina Lecture, delivered at the virtual Euretina congress, SriniVas Sadda, MD, highlighted the critical role of the choriocapillaris in age-related macular degeneration.Studies with OCT angiography have shown that the choriocapillaris…
Uveitis Drug Pipeline Landscape Research Report 2021 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Uveitis (Ophthalmology) – Drugs In Development, 2021” report has been added to ResearchAndMarkets.com’s offering. Uveitis – Drugs In Development, 2021, provides an overview of the Uveitis (Ophthalmology) pipeline landscape…
FDA: Prescribers can help stop false or misleading prescription drug promotion
It is estimated that the pharmaceutical industry spent more than $24 billion on prescription drug promotion in 2017.Prescription drug promotion can provide prescribers with information about the latest drug therapies and may be part of their decision-m…
Global Refractive Surgery Devices Market (2021 to 2028) – Size, Share & Trends Analysis Report – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Refractive Surgery Devices Market Size, Share & Trends Analysis Report by Application (Myopia, Astigmatism), by Product (Lasers, Aberrometers), by End Use (Hospitals, Ambulatory Surgery Centers), and Segment For…
AbbVie, Regenxbio to develop, commercialize RGX-314 for retinal diseases
AbbVie and Regenxbio have entered into a partnership to develop and commercialize RGX-314, an investigational gene therapy, for the treatment of retinal diseases, according to a press release.Regenxbio will be responsible for completing ongoing trials,…
VisualCamp Chosen as Representative Korean Startup at TechCrunch Disrupt 2021
SEOUL, South Korea–(BUSINESS WIRE)– #2021SLINGSHOTTop500GlobalStartups–VisualCamp was selected to represent one of Korea’s pioneering startups at TechCrunch Disrupt 2021, thanks to its AI-based eye tracking SDK, SeeSo.